Mode of action of ponazuril against Toxoplasma gondii tachyzoites in cell culture.

This research study explores how the drug ponazuril affects the growth and survival of Toxoplasma gondii, a parasite, in infected African green monkey kidney cells.

Introduction to Toxoplasma gondii and Ponazuril

• Toxoplasma gondii is a type of parasite that can infect humans and various warm-blooded animals.
• Ponazuril is an anti-parasitic drug that is mainly used to treat infections caused by parasites. Recently, the drug has been approved for use in horses in the United States.
• The aim of this study was to understand how ponazuril works to combat the T. gondii infection within cell cultures, specifically within African green monkey kidney cells.

Methodology

• In order to observe the action of the drug, the researchers infected African green monkey kidney cells with a strain of T. gondii called the RH strain.
• The cells were then treated with ponazuril in a concentration of 5 micrograms per milliliter.
• After treatment, the cells were fixed and observed under a transmission electron microscope after three days.

Observations and Conclusions

• When examined under the electron microscope, the researchers noticed abnormalities in the division process of the parasites. Ponazuril seemed to hinder the normal division of the parasites.
• This interference caused the formation of multinucleate schizont stages, a stage in the life cycle of the parasite in which it holds more than one nucleus.
• In certain schizont stages, the formation of as many as six tachyzoites, or rapidly dividing forms of the parasite, was observed partially budding from the surface.
• Large vacuoles, which are enclosed compartments within a cell that contain various substances, were seen within these schizonts. Over time, these schizonts with large vacuoles appeared to degenerate.
• The study concluded that ponazuril induces changes in the life cycle and division process of T. gondii, leading to abnormal forms and eventual degeneration of the parasites.